Correction: The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis

Correction: The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis

Show other versions (1)

Bibliographic Details
Main Authors:	Sabrina Cipriani, Andrea Mencarelli, Maria Giovanna Chini, Eleonora Distrutti, Barbara Renga, Giuseppe Bifulco, Franco Baldelli, Annibale Donini, Stefano Fiorucci
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608858/?tool=EBI

Similar Items

The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis.
by: Sabrina Cipriani, et al.
Published: (2011-01-01)

Correction: The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis.
by: Sabrina Cipriani, et al.
Published: (2013-01-01)

GPBAR1/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells.
by: Guiyu Lou, et al.
Published: (2014-01-01)

The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice.
by: Andrea Mencarelli, et al.
Published: (2010-01-01)

The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver
by: Caroline Klindt, et al.
Published: (2019-11-01)

Identification of miR-26a as a target gene of bile acid receptor GPBAR-1/TGR5.
by: Xiaosong Chen, et al.
Published: (2015-01-01)

Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation.
by: Andrea Mencarelli, et al.
Published: (2011-01-01)

The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation.
by: Barbara Renga, et al.
Published: (2013-01-01)

Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome.
by: Eleonora Distrutti, et al.
Published: (2013-01-01)

VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation.
by: Andrea Mencarelli, et al.
Published: (2012-01-01)

Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1.
by: Barbara Renga, et al.
Published: (2015-01-01)

The G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits gastric inflammation through antagonizing NF-kB signaling pathway
by: Cong eGuo, et al.
Published: (2015-12-01)

Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling.
by: Sabrina Cipriani, et al.
Published: (2015-01-01)

Hydrogen sulphide induces μ opioid receptor-dependent analgesia in a rodent model of visceral pain
by: Distrutti Eleonora, et al.
Published: (2010-06-01)

GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated HepatitisSummary
by: Michele Biagioli, et al.
Published: (2019-01-01)

Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation
by: Adriana Carino, et al.
Published: (2019-05-01)

Bile Acids Activated Receptors Regulate Innate Immunity
by: Stefano Fiorucci, et al.
Published: (2018-08-01)

Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome
by: Piero Portincasa, et al.
Published: (2020-11-01)

Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP.
by: Eleonora Distrutti, et al.
Published: (2014-01-01)

A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo.
by: Nuruddeen D Lewis, et al.
Published: (2014-01-01)

Collagenous colitis : The influence of inflammation and bile acids on intestinal barrier function
by: Münch, Andreas
Published: (2010)

Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.
by: Johannes R Hov, et al.
Published: (2010-08-01)

Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis
by: Madeleine Spatz, et al.
Published: (2021-04-01)

TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload
by: Valeska Bidault-Jourdainne, et al.
Published: (2021-04-01)

The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes.
by: Barbara Renga, et al.
Published: (2012-01-01)

Baitouweng Tang ameliorates DSS-induced ulcerative colitis through the regulation of the gut microbiota and bile acids via pathways involving FXR and TGR5
by: Yong-li Hua, et al.
Published: (2021-05-01)

Bile Acids Activated Receptors in Inflammatory Bowel Disease
by: Michele Biagioli, et al.
Published: (2021-05-01)

Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
by: Kavita Jadhav, et al.
Published: (2018-03-01)

Regulation of Pancreatic α and β Cell Function by the Bile Acid Receptor TGR5
by: Prasanna Kumar, Divya
Published: (2014)

Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
by: Sachiho Miyata, et al.
Published: (2021-04-01)

Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5
by: Samuel A. J. Trammell, et al.
Published: (2020-05-01)

Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte DysfunctionSummary
by: Julia Leonhardt, et al.
Published: (2021-01-01)

Sarcopenia Induced by Chronic Liver Disease in Mice Requires the Expression of the Bile Acids Membrane Receptor TGR5
by: Johanna Abrigo, et al.
Published: (2020-10-01)

Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis.
by: Barbara Renga, et al.
Published: (2012-01-01)

Diabetes-Induced Expression and Regulation of GLP-1 levels by Bile Acid Receptors (TGR5 & FXR)
by: Spengler, Joseph R
Published: (2017)

FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats[S]
by: Sabrina Cipriani, et al.
Published: (2010-04-01)

Solomonsterol A, a Marine Pregnane-X-Receptor Agonist, Attenuates Inflammation and Immune Dysfunction in a Mouse Model of Arthritis
by: Andrea Mencarelli, et al.
Published: (2013-12-01)

Allspice and Clove As Source of Triterpene Acids Activating the G Protein-Coupled Bile Acid Receptor TGR5
by: Angela Ladurner, et al.
Published: (2017-07-01)

MEMBRANE BILE ACID RECEPTOR TGR5 - A NEW TARGET IN THE STUDY OF METABOLIC, INFLAMMATORY AND NEOPLASTIC DISEASES
by: O. M. Drapkina, et al.
Published: (2016-06-01)

Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties
by: Michele Biagioli, et al.
Published: (2019-02-01)